5 Best Performing Biotech ETFs in 2024
The Putnam BioRevolution ETF (NYSE:SYNB) is designed to pursue long-term capital growth by investing in a carefully curated portfolio of 30-50 stocks.
Ishares Trust (IBB)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Bourgeon Capital John Zaro | 4,424 | $565,830 | +5% | 0.12% |
| 2. | Solstein Capital Nadine Terman And Jc Torres | 330 | $42,207 | -35% | 0.02% |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 71,000 | $9,080,900 | 0.11% | |
| 2. | 69,865 | $8,935,711 | 1.42% | |
| 3. | 64,112 | $8,199,925 | 0.92% | |
| 4. | 41,921 | $5,361,514 | 0.01% | |
| 5. | 39,667 | $5,073,421 | 0.4% |
News See All
11 Best Biotech ETFs To Buy
The new era in biotech is defined by the convergence of biology, data, and artificial intelligence.
12 Best Healthcare ETFs To Buy
In December 2022, BlackRock highlighted concerns about the performance for the healthcare sector in 2023. The previous year was rather challenging for equity and fixed income markets.
12 Best Biotech ETFs To Buy
According to Precedence Research, the worldwide biotechnology market was valued at approximately $1,224.31 billion in 2022.
10 Best Small Cap Pharma Stocks to Buy
In this piece, we will take a look at the ten best small cap pharma stocks to buy.
Trumpdesivir: Operation Warp Speed, “Engage.”
The COVID-19 vaccine race officially goes into high gear with the announcement of USA’s plan to test the 6-odd top vaccine candidates across upwards of 150,000 volunteers (min.
3 Mistakes To Avoid When Choosing The Perfect Closed-End Fund
The closed-end fund marketplace is one of over 500 offerings that span virtually every global asset class.
Trump Supporters Icahn, Paulson Score Huge Returns After Election Win
Just like Main Street, this election season also saw Wall Street divided into two factions based on who they supported.
Julian Robertson Likes Biotech, Talks Up Microsoft (MSFT), Apple (AAPL) & Gilead (GILD)
Legendary investor Julian Robertson, founder of Tiger Management, sees tremendous upside in biotech stocks right now. The billionaire told CNBC in a recent interview that fears of what could befall...
Should You Buy iShares NASDAQ Biotechnology Index (ETF) (IBB)?
How do you pick the next stock to invest in? One way would be to spend hours of research browsing through thousands of publicly traded companies.
Billionaire Hedge Funds
